Pioneering diagnostics

Committed to being a socially responsible company, with a humanistic vision

As a pioneer in the field of in vitro diagnostics for more than 55 years, bioMérieux has always combined economic development with a socially responsible, humanistic approach in line with the values upheld by the Mérieux family.

bioMérieux’s actions extend beyond our products and services. They reflect a broader vision of society, with the ambition of contributing to the fight against infectious diseases worldwide and addressing major public health challenges such as antimicrobial resistance. 

Through its tangible accomplishments, this vision supports the United Nations Sustainable Development Goals and upholds the principles of the UN Global Compact.

The UN Global Compact

bioMérieux has been a member of the United Nations Global Compact since 2003. The Global Compact’s key principles have guided our initiatives over the course of 2017. From the beginning, our Company has always placed great importance on implementing initiatives that promote respect for human rights, labor conditions, the environment and the fight against corruption, which comprise the four pillars that ensure the strength of the Global Compact.

Recognition of our corporate social responsability policy

In past years, bioMérieux integrated Socially Responsible Investment (SRI) indices. This includes the Ethibel Forum (Ethibel Sustainability Index (ESI) Excellence Europe), which builds on the work of the rating agency Vigeo, and the FTSE Russell (FTSE4-Good Index). In 2017, the Company joined additional indices and obtained new labels: Vigeo Eiris, OEKOM Research, CDP and EcoVadis, which is a platform for rating corporate social and environmental performance. EcoVadis ranked bioMérieux among the top 5% of companies for excellent CSR performance, recognition of the Company’s ongoing efforts to reconcile a sustainable social commitment to serving public health with business development.